Office of the Director, National Institutes of Health; Notice of Meeting, 51466-51467 [2010-20675]
Download as PDF
51466
Federal Register / Vol. 75, No. 161 / Friday, August 20, 2010 / Notices
components of the Medicare hospital
outpatient prospective payment system
(OPPS).
The APC Panel meets up to three
times annually. The Charter requires
that the Panel must be fairly balanced in
its membership in terms of the points of
view represented and the functions to
be performed. The Panel consists of up
to 15 members, who are representatives
of providers, and a Chair. Each Panel
member must be employed full-time by
a hospital, hospital system, or other
Medicare provider subject to payment
under the OPPS. The Secretary or the
Administrator of the Centers for
Medicare & Medicaid Services (the
Administrator) selects the Panel
membership based upon either selfnominations or nominations submitted
by Medicare providers and other
interested organizations. All members
must have technical expertise to enable
them to participate fully in the work of
the Panel. This expertise encompasses
hospital payment systems; hospital
medical-care delivery systems; provider
billing systems; APC groups, Current
Procedural Terminology codes, and
alpha-numeric Healthcare Common
Procedure Coding System codes; and
the use of, and payment for, drugs and
medical devices in the outpatient
setting, as well as other forms of
relevant expertise.
The Charter requires that all members
have a minimum of 5 years experience
in their area(s) of expertise, but it is not
necessary that any member be an expert
in all of the areas listed above. For
purposes of this Panel, consultants and
independent contractors are not
considered as representatives of
providers. A Panel member may serve
up to a 4-year term. A member may
serve after the expiration of his or her
term until a successor has been sworn
in. All terms are contingent upon the
renewal of the Panel by appropriate
action before its termination. The
Secretary re-chartered the APC Panel
effective November 21, 2008.
II. Announcement of New Members
The Panel may consist of a Chair and
up to 15 Panel members who serve
without compensation, according to an
advance written agreement. Travel,
meals, lodging, and related expenses for
the meeting are reimbursed in
accordance with standard Government
travel regulations. We have a special
interest in ensuring that women,
minorities, representatives from various
geographical locations, and the
physically challenged are adequately
represented on the Panel.
The Secretary, or her designee,
appoints new members to the Panel
from among those candidates
determined to have the required
expertise. New appointments are made
in a manner that ensures a balanced
membership.
The Panel presently consists of the
following 15 members and a Chair: (The
asterisk [*] indicates a Panel member
whose term expires on September 30,
2010.)
• Edith Hambrick, M.D., J.D., Chair
• Ruth L. Bush, M.D., M.P.H.
• Dawn L. Francis, M.D., M.H.S.
• Kathleen M. Graham, R.N.,
M.S.H.A., C.P.H.Q.
• Patrick Grusenmeyer, Sc.D., M.P.A.,
F.A.C.H.
• David Halsey, M.D.
• Judith T. Kelly, B.S.H.A., R.H.I.T.,
R.H.I.A., C.C.S.
• Michael D. Mills, Ph.D., M.S.P.H.*
• Agatha L. Nolen, D.Ph., M.S.,
F.A.S.H.P.
• Randall A. Oyer, M.S.
• Beverly Khnie Philip, M.D.*
• Daniel Pothen, M.S., R.H.I.A.,
CPHIMS, CCS, CCS–P, CHC
• Gregory J. Przybylski, M.D.
• Russ Ranallo, M.S.*
• Michael A. Ross, M.D., F.A.C.E.P.*
• Patricia Spencer-Cisek, M.S.,
A.P.R.N.-BC, A.O.C.N.®*
On March 26, 2010, we published a
notice in the Federal Register entitled
‘‘Medicare Program; Request for
Nominations to the Advisory Panel on
Ambulatory Payment Classification
Groups’’ (CMS–1570–N) requesting
nominations to the Panel replacing
Panel members whose terms would
expire on September 30, 2010. As a
result of that Federal Register notice,
we are announcing five new members to
the Panel. All five appointments are for
4-year terms commencing on October 1,
2010, as indicated below:
New panel members
•
•
•
•
•
Kari S. Cornicelli, C.P.A., FHFMA ........................................................................................................................
Brian D. Kavanagh, M.D., M.P.H ..........................................................................................................................
Scott Manaker, M.D., PhD ....................................................................................................................................
John Marshall, C.R.A., R.C.C., RT ® ....................................................................................................................
Neville B. Sarkari, M.D., FACP .............................................................................................................................
(Note: Dr. Kavanagh replaces Dr.
Mills; Dr. Manaker replaces Dr. Philip;
Dr. Sarkari replaces Dr. Ross; Ms.
Cornicelli replaces Mr. Ranallo; and Mr.
Marshall replaces Ms. Spencer-Cisek.
They will all take the Oaths of Office at
the winter 2011 APC Panel meeting.
Therefore, the current APC Panel
members are all invited to attend the
2010 late summer meeting since the
new members’ terms do not begin until
October 1, 2010.)
sroberts on DSKD5P82C1PROD with NOTICES
Terms
17:19 Aug 19, 2010
Jkt 220001
9/30/2014.
9/30/2014.
9/30/2014.
9/30/2014.
9/30/2014.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
National Institutes of Health
Dated: August 11, 2010.
Donald M. Berwick,
Administrator, Centers for Medicare &
Medicaid Services.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
BILLING CODE 4120–01–P
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
VerDate Mar<15>2010
through
through
through
through
through
Budget under the authority of the
Paperwork Reduction Act of 1995.
[FR Doc. 2010–20306 Filed 8–19–10; 8:45 am]
III. Collection of Information
Requirements
10/1/2010
10/1/2010
10/1/2010
10/1/2010
10/1/2010
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Office of the Director, National
Institutes of Health; Notice of Meeting
E:\FR\FM\20AUN1.SGM
20AUN1
Federal Register / Vol. 75, No. 161 / Friday, August 20, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the Scientific Management Review
Board (also referred to as SMRB or
Board) is to advise appropriate HHS and
NIH officials on the use of these
organizational authorities and identify
the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board.
Date: September 14–15, 2010.
Time: September 14, 2010, 8:30 a.m. to
5:30 p.m.
Agenda: The focus of this meeting will be
on the deliberations of the Translational
Medicine and Therapeutics working group
and its respective stakeholder consultation.
Presentation and discussion will include, but
is not limited to, representatives from
academia, government, industry, venture
capital firms, and patient advocacy groups.
Additional presentation and discussion will
include recommendations from the
Substance Use, Abuse and Addiction
working group and the Intramural Research
Program working group. Time will be allotted
both days for presentation and discussion of
each Working Group’s recommendations.
Any supporting documentation for this
meeting, including the agenda, will be
available at https://smrb.od.nih.gov. Sign up
for public comment will begin at
approximately 7:30 a.m. on both September
14 and 15 and will be restricted to one sign
in per person. In the event that time does not
allow for all those interested to present oral
comments, anyone may file written
comments using the contact person’s address
below.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Time: September 15, 2010, 8 a.m. to 5 p.m.
Agenda: Continuation of September 14th
meeting.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Lyric Jorgenson, Health
Sciences Policy Analyst Office of Science
Policy, Office of the Director, NIH, National
Institutes of Health, Building 1, Room 218,
MSC 0166, 9000 Rockville Pike, Bethesda,
MD 20892, smrb@mail.nih.gov, (301) 496–
6837.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
VerDate Mar<15>2010
17:19 Aug 19, 2010
Jkt 220001
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will also be webcast. The draft
meeting agenda and other information about
the SMRB, including information about
access to the webcast, will be available at
https://smrb.od.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: August 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–20675 Filed 8–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0423]
ASK (Assess Specific Kinds of
CHILDREN Challenges for Neurologic
Devices) Study Children Workshop;
Public Workshop; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
The Food and Drug
Administration (FDA) is announcing a
public workshop entitled ASK (Assess
Specific Kinds of CHILDREN Challenges
for Neurologic Devices) Study Children
Workshop. The purpose of the public
workshop is to solicit comments from
academic investigators and clinicians
associated with the use, research and/or
development of pediatric
neuroprostheses regarding approaches
for enhancing the protection and
promotion of public health in children
and adolescents with neuroprostheses.
The public workshop will provide an
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
51467
overview of pediatric initiatives across
the Agency, neurological and
neurosurgical perspectives on medical
devices, a review of pediatric
assessments and outcome measures, and
scientific research issues associated
with the use of neuroprotheses in
pediatric populations, including
cochlear implants, deep brain
stimulators, hydrocephalus shunts,
spinal cord stimulators, and vagus nerve
stimulators. Information from this
public workshop will help establish a
science-based framework of
recommendations to aid in the
development of more efficient strategies
in evaluating pediatric neuroprostheses
regulated by the Agency.
Dates and Time: The public workshop
will be held on September 13, 2010,
from 9 a.m. to 5 p.m.
Location: The public workshop will
be held at FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31,
Conference Center, rm. 1503, Silver
Spring, MD 20993. For lodging and
directions, please refer to the meeting
on the Internet at: https://www.fda.gov/
MedicalDevices/NewsEvents/
WorkshopsConferences/default.htm.
˜
Contact Person: Carlos Pena, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, rm. 4264,
Silver Spring, MD 20993–0002, 301–
796–8521, FAX: 301–847–8617, email:
carlos.pena@fda.hhs.gov.
Registration: Registration requests
must be received by 5 p.m. on
September 6, 2010. If you wish to attend
the public meeting, you must register
online at: https://www.fda.gov/
MedicalDevices/NewsEvents/
WorkshopsConferences/default.htm.
There is no registration fee for the
public workshop. Early registration is
recommended because seating is
limited. There will be no onsite
registration.
If you wish to make an oral
presentation at the workshop, you must
indicate this at the time of registration.
FDA will do its best to accommodate
requests to speak. Individuals and
organizations with common interests are
urged to consolidate or coordinate their
presentations, and to request time for a
joint presentation. FDA will determine
the amount of time allotted to each
presenter and the approximate time that
each oral presentation is scheduled to
begin.
If you wish to make an oral
presentation during the open comment
period at the workshop, you must
indicate this at the time of registration.
FDA requests that presentations focus
on the areas described in this notice.
You should also identify which
discussion topic you wish to address in
E:\FR\FM\20AUN1.SGM
20AUN1
Agencies
[Federal Register Volume 75, Number 161 (Friday, August 20, 2010)]
[Notices]
[Pages 51466-51467]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20675]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L. 109-482) provides
organizational authorities to HHS and NIH officials to: (1) Establish
or abolish national research institutes; (2) reorganize the offices
within the Office of the Director, NIH including adding, removing, or
transferring the functions of such offices
[[Page 51467]]
or establishing or terminating such offices; and (3) reorganize,
divisions, centers, or other administrative units within an NIH
national research institute or national center including adding,
removing, or transferring the functions of such units, or establishing
or terminating such units. The purpose of the Scientific Management
Review Board (also referred to as SMRB or Board) is to advise
appropriate HHS and NIH officials on the use of these organizational
authorities and identify the reasons underlying the recommendations.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Scientific Management Review Board.
Date: September 14-15, 2010.
Time: September 14, 2010, 8:30 a.m. to 5:30 p.m.
Agenda: The focus of this meeting will be on the deliberations
of the Translational Medicine and Therapeutics working group and its
respective stakeholder consultation. Presentation and discussion
will include, but is not limited to, representatives from academia,
government, industry, venture capital firms, and patient advocacy
groups. Additional presentation and discussion will include
recommendations from the Substance Use, Abuse and Addiction working
group and the Intramural Research Program working group. Time will
be allotted both days for presentation and discussion of each
Working Group's recommendations. Any supporting documentation for
this meeting, including the agenda, will be available at https://smrb.od.nih.gov. Sign up for public comment will begin at
approximately 7:30 a.m. on both September 14 and 15 and will be
restricted to one sign in per person. In the event that time does
not allow for all those interested to present oral comments, anyone
may file written comments using the contact person's address below.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Time: September 15, 2010, 8 a.m. to 5 p.m.
Agenda: Continuation of September 14th meeting.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Lyric Jorgenson, Health Sciences Policy Analyst
Office of Science Policy, Office of the Director, NIH, National
Institutes of Health, Building 1, Room 218, MSC 0166, 9000 Rockville
Pike, Bethesda, MD 20892, smrb@mail.nih.gov, (301) 496-6837.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
The meeting will also be webcast. The draft meeting agenda and
other information about the SMRB, including information about access
to the webcast, will be available at https://smrb.od.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: August 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20675 Filed 8-19-10; 8:45 am]
BILLING CODE 4140-01-P